Malaysia to India Pharmaceutical Import
Bilateral Trade Intelligence · $14.7M Total Trade · 54 Foreign Suppliers · 49 Indian Buyers · DGFT Verified · Updated March 2026
India imported $14.7M worth of pharmaceutical formulations from Malaysia across 369 verified shipments, from 54 foreign suppliers to 49 Indian buyers. The top suppliers are B BRAUN MEDICAL INDUSTRIES SDN BHD ($10.1M) and BIOCON SDN BHD ($3.0M). The leading products are Plasma ($10.5M) and Insulin ($3.9M). Average shipment value: $39.9K.
Top Pharmaceutical Formulations — Malaysia to India
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Plasma | $10.5M | 71.4% |
| 2 | Insulin | $3.9M | 26.5% |
| 3 | Metformin | $247.6K | 1.7% |
| 4 | Valsartan | $9.7K | 0.1% |
| 5 | Sitagliptin | $6.8K | 0.0% |
| 6 | Apixaban | $5.6K | 0.0% |
| 7 | Amlodipine | $4.6K | 0.0% |
| 8 | Hydrochlorothiazide | $3.3K | 0.0% |
| 9 | Enalapril | $3.3K | 0.0% |
| 10 | Bisoprolol | $3.2K | 0.0% |
| 11 | Sodium | $3.0K | 0.0% |
| 12 | Rivaroxaban | $2.7K | 0.0% |
| 13 | Vildagliptin | $2.2K | 0.0% |
| 14 | Dolutegravir | $2.1K | 0.0% |
| 15 | Ceftazidime | $1.8K | 0.0% |
India imports 20+ pharmaceutical formulations from Malaysia with a combined trade value of $14.7M. Key products include Plasma ($10.5M), Insulin ($3.9M), Metformin ($248K), Valsartan ($10K), Sitagliptin ($7K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 369 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — Malaysia to India Trade Routes
These are the top pharmaceutical products exported from India to Malaysia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Malaysia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Plasma ($10.5M), Insulin ($3.9M), Metformin ($248K), Valsartan ($10K), Sitagliptin ($7K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Malaysia Suppliers to India
54 Indian pharmaceutical companies export finished formulations to Malaysia. Leading exporters include B Braun Medical Industries Sdn Bhd, Biocon Sdn Bhd, Xxocoxxsdnxxhd, B Braun Medical Industries Sdn. Bhd.. The top exporter accounts for 68.8% of total India–Malaysia pharma exports. Source: Indian Customs (DGFT).
Top Indian Buyers from Malaysia
49 companies in Malaysia import pharmaceutical formulations from India. Top buyers include B Braun Medical India Private Limited, Biocon Biologics Limited, Biocon Biologics India Limited, B.braun Medical (india) Private Limited. The largest buyer accounts for 68.8% of India–Malaysia pharma imports. Source: Indian Customs (DGFT).
Trade Statistics
Other Import Origins
Product Routes
FAQ — India to Malaysia Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Malaysia?
India exported pharmaceuticals worth $14.7M to Malaysia across 369 verified shipments.
Who are the top Indian pharmaceutical exporters to Malaysia?
1. B BRAUN MEDICAL INDUSTRIES SDN BHD — $10.1M. 2. BIOCON SDN BHD — $3.0M. 3. XXOCOXXSDNXXHD — $950.6K. Total: 54 suppliers.
Which companies in Malaysia import pharmaceuticals from India?
1. B BRAUN MEDICAL INDIA PRIVATE LIMITED — $10.1M. 2. BIOCON BIOLOGICS LIMITED — $2.3M. 3. BIOCON BIOLOGICS INDIA LIMITED — $1.6M. 49 buyers total.
What pharmaceutical products does India export most to Malaysia?
1. Plasma ($10.5M, 71.4%); 2. Insulin ($3.9M, 26.5%); 3. Metformin ($247.6K, 1.7%); 4. Valsartan ($9.7K, 0.1%); 5. Sitagliptin ($6.8K, 0.0%)
Which ports handle pharmaceutical shipments from India to Malaysia?
Export: . Import: .
Why does Malaysia import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $14.7M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Malaysia?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Malaysia pharmaceutical trade?
$39.9K per consignment across 369 shipments.
How many Indian pharmaceutical companies export to Malaysia?
54 Indian companies. Largest: B BRAUN MEDICAL INDUSTRIES SDN BHD with $10.1M.
How can I find verified Indian pharmaceutical suppliers for Malaysia?
TransData Nexus covers 54 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Malaysia Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 369 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Malaysia identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 369 verified shipments from 54 Indian exporters to 49 Malaysia buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
54 Exporters
49 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists